Natural Health Products Ingredients Database

WHAT'S NEW

What's New is a listing of modifications to the NHPID since the last update. This page was most recently revised on October 17, 2018.

Announcements
New Ingredients
Removed Ingredients
Revised NHPID Names
Revised Proper and Common Names
New Roles
Revised Restrictions
Other Ingredient Modifications
Monograph Modifications
AbLS Modifications
Controlled Vocabulary Modifications
Homeopathic Ingredient Modifications
Previous What's New

Top of Page

ANNOUNCEMENTS

The updates to the NHPID listed below apply to the most recent version of the ePLA (electronic Product Licence Application). All new electronic submissions of a Product Licence Application must use the latest version of the e-PLA, namely version 2.3.1, which is available for downloading from e-PLA 2.3.1

Top of Page

New Ingredients

In this update, the following non-homeopathic ingredients were added.

NHPID Name:

Citrus Aurantium Amara (Bitter Orange) Leaf/Twig Extract

Role:

Non-medicinal

NHPID Name:

Tecoma stans

Role:

Medicinal

NHPID Name:

Rabdosia Rubescens Extract

Role:

Non-medicinal

NHPID Name:

Acetyl Tetrapeptide-5

Role:

Non-medicinal

NHPID Name:

Calcium saccharate tetrahydrate

Role:

Chemical Substance

Top of Page

Removed Ingredients

In this update, the following non-homeopathic ingredients were removed.

No Changes.

Top of Page

Revised NHPID Names

In this update, the following non-homeopathic ingredients had their NHPID name revised.

Old NHPID Name:

2-Biphenylol, sodium salt

New NHPID Name:

Sodium o-phenylphenate

Top of Page

Revised Proper and Common Names

In this update, the following non-homeopathic ingredients had their common or proper names revised.

NHPID Name:

Butylated hydroxyanisole

New Common Name(s):

BHA

NHPID Name:

PhEur_Strychnos ignatii

New Proper Name(s):

Ignatia

NHPID Name:

Sodium o-phenylphenate

Removed Common Name(s):

Sodium 2-biphenylate

NHPID Name:

Sodium o-phenylphenate

New Common Name(s):

Sodium o-phenylphenate, Sodium o-phenylphenol

Top of Page

New Roles

In this update, the roles of the following non-homeopathic ingredients were changed.

No Changes.

Top of Page

Revised Restrictions

In this update, the following non-homeopathic ingredients underwent a modification related to their restrictions.

NHPID Name:

Cannabis sativa

Medicinal Restriction(s) Changed :

The above ingredients must not contain more than 10 parts per million delta-9-Tetrahydrocannabinol (THC), or phytocannabinoids that have been isolated or concentrated. The determination of the THC concentration must take into account the potential to convert delta-9-tetrahydrocannabinolic acid (THCA) to THC. Hemp derivatives must also be compliant with the IHR. All sources of hemp falling under the IHR are expected to be of an approved cultivar, defined in the IHR as any variety of industrial hemp set out in the List of Approved Cultivars, published by the Government of Canada on its website, as amended from time to time

NHPID Name:

Semen Cannabis

Medicinal Restriction(s) Changed :

The ingredient must not contain more than 10 parts per million delta-9-Tetrahydrocannabinol (THC), or phytocannabinoids that have been isolated or concentrated; and, in accordance with its use as Traditional Chinese Medicine, seeds must be crushed and stir-fried. The determination of the THC concentration must take into account the potential to convert delta-9-tetrahydrocannabinolic acid (THCA) to THC. Hemp derivatives must also be compliant with the IHR. All sources of hemp falling under the IHR are expected to be of an approved cultivar, defined in the IHR as any variety of industrial hemp set out in the List of Approved Cultivars, published by the Government of Canada on its website, as amended from time to time.

NHPID Name:

Cannabis sativa Seed Oil

Medicinal Restriction(s) Changed :

The ingredient must not contain more than 10 parts per million delta-9-Tetrahydrocannabinol (THC), or phytocannabinoids that have been isolated or concentrated. The determination of the THC concentration must take into account the potential to convert delta-9-tetrahydrocannabinolic acid (THCA) to THC. Hemp derivatives must also be compliant with the IHR. All sources of hemp falling under the IHR are expected to be of an approved cultivar, defined in the IHR as any variety of industrial hemp set out in the List of Approved Cultivars, published by the Government of Canada on its website, as amended from time to time.

NHPID Name:

Cannabis sativa Seed Oil

Non-medicinal Restriction(s) removed:

Oral Route of Adminstration

NHPID Name:

Cannabis sativa Seed Oil

Non-medicinal Restriction(s) changed:

NHPID Name:

Cannabis sativa Seed Oil

Route(s) of Adminstration removed:

Topical; Skin-Conditioning Agent

NHPID Name:

Cannabis sativa Seed Oil

Non-medicinal Restriction(s) changed:

For topical use only

NHPID Name:

Hemp Protein Concentrate

Medicinal Restriction(s) removed:

Oral Route of Adminstration

NHPID Name:

Hemp Protein Concentrate

Medicinal Restriction(s) Changed :

NHPID Name:

Hemp Protein Isolate

Medicinal Restriction(s) removed:

Oral Route of Adminstration

NHPID Name:

Hemp Protein Isolate

Medicinal Restriction(s) Changed :

NHPID Name:

Hemp Seed Protein

Medicinal Restriction(s) removed:

Oral Route of Adminstration

NHPID Name:

Hemp Seed Protein

Medicinal Restriction(s) Changed :

NHPID Name:

Sodium o-phenylphenate

New Route(s) of Adminstration added:

Topical: Up to 0.2%, expressed as 2-biphenylol equivalents.

NHPID Name:

Sodium o-phenylphenate

New Route(s) of Adminstration added:

Oral

Top of Page

Other Ingredient Modifications

In this update, the following non-homeopathic ingredients underwent a modification different from those listed above, such as new source material, new preparation type, or new sub-ingredient relationship, etc.

NHPID Name:

Cannabis sativa

Medicinal Rationale changed:

Classified as an NHP under Schedule 1 of the Natural Health Products Regulations. NHPs can only contain cannabis parts which either do not meet the definition of cannabis in the Cannabis Act, or that have been exempted from the Cannabis Act through the Industrial Hemp Regulations (IHR). These ingredients are: non-viable seeds or roots of the cannabis plant; mature cannabis stalks without leaves, flowers, seeds, or branches; fibre derived from such a stalk; and hemp derivatives that are compliant with the IHR.

NHPID Name:

Cannabis sativa

Non-NHP Rationale changed:

A non-NHP when the ingredient meets the definition of cannabis in the Cannabis Act: 1. Any part of a cannabis plant, including the phytocannabinoids produced by, or found in, such a plant, regardless of whether that part has been processed or not, other than a part of the plant referred to in Schedule 2; 2. Any substance or mixture of substances that contains or has on it any part of such a plant; and, 3. Any substance that is identical to any phytocannabinoid produced by, or found in, such a plant, regardless of how the substance was obtained. Phytocannabinoids are also listed on the Prescription Drug List as follows: Phytocannabinoids produced by, or found in, the cannabis plant and substances that are duplicates of such phytocannabinoids, except: (a) derivatives of cannabis as defined in subsection 2(1) of the Cannabis Act that are exempt from the application of the Cannabis Act under the Industrial Hemp Regulations and that do not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid, or (b) anything referred to in Schedule 2 to the Cannabis Act that contains no more than 10 µg/g delta-9-tetrahydrocannabinol and that does not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid.

NHPID Name:

Semen Cannabis

Medicinal Rationale changed:

Classified as an NHP under Schedule 1 of the Natural Health Products Regulations. The ingredient is non-viable seed of the cannabis plant, not meeting the definition of cannabis in the Cannabis Act; or, is a hemp derivative exempt from the Cannabis Act through the Industrial Hemp Regulations (IHR).

NHPID Name:

Cannabis sativa Seed Oil

Medicinal Rationale changed:

Classified as an NHP under Schedule 1, item 2 (extract) of the Natural Health Products Regulations. The ingredient is a hemp derivative exempt from the Cannabis Act through the Industrial Hemp Regulations (IHR).

NHPID Name:

Cannabis sativa Seed Oil

Removed NMI purpose(s):

Dispersing Agent

NHPID Name:

Cannabis sativa Seed Oil

Removed NMI purpose(s):

Oleaginous Vehicle

NHPID Name:

Hemp Protein Concentrate

Medicinal Rationale changed:

NHPID Name:

Hemp Protein Isolate

Medicinal Rationale changed:

NHPID Name:

Hemp Seed Protein

Medicinal Rationale changed:

NHPID Name:

Solanum lycopersicum (Part: Fruit)

New Sub-ingredient(s) added:

Phytoene and Phytofluene

NHPID Name:

Sodium gluconate

New NMI Purpose(s):

Chelating Agent (Oral)

NHPID Name:

Zinc gluconate

New NMI Purpose(s):

Chelating Agent (Oral)

NHPID Name:

Sodium o-phenylphenate

New Toxicity restriction added:

Acceptable Daily Intake: Upper Limit: 0.2 Units: Milligrams/kilogram body weight/day Detail: Acceptable daily intake up to 0.2 mg/kg bw/day. Dose journalière acceptable jusqu'à 0.2 mg/kg pc/jour.

Top of Page